Literature DB >> 27620660

Cytotoxic ethnic Yao medicine Baizuan, leaves of Schisandra viridis A. C. Smith.

Xiaotao Hou1, Jiagang Deng2, Qian Zhang3, Dongdong Wang3, Derek Kennedy3, Ronald J Quinn3, Yunjiang Feng4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The ethnic Chinese Yao medicine Baizuan, which are the leaves of Schisandra viridis A. C. Smith, is traditionally used, in combination with other herbs, to soften hard lumps and dispel nodes in the treatment of cancer, however, this property has not been well studied with a clear indication of the active principles. AIM OF THE STUDY: The experiments were carried out to investigate the cytotoxic activity of the extracts and to identify the active principles from the extract, which could support the traditional application of treating cancer.
MATERIALS AND METHODS: Dried and ground plant material was extracted with water and ethanol and further purified by HPLC. The cytotoxicity of the extracts, fractions and pure compounds were evaluated for their abilities to inhibit the proliferation of breast cancer cells MCF7 and tongue cancer cells CAL27. The cytotoxicity of the pure compounds were also tested against Human Embryonic Kidney cell line HEK293.
RESULTS: Both aqueous and ethanol extracts showed activities against MCF7 and CAL27 cancer cells. Bioassay-guided fractionation and purification of the extracts resulted in six active principles, including five dibenzocyclooctene lignans namely gomisin H (1), schisandrin (2), angeloylgomisin H (3), (+)-gomisin M2 (4) and (-)-rubschisandrin (5), and one triterpenoid, schisanol (6). Compounds 1-3 showed moderate cytotoxic activities with IC50 values ranging from 100 to 200µg/mL against MCF7 and CAL27 cell lines. Dioxane containing lignans 4-5 and triterpenoid 6 were 10 times more active with IC50 values of 14.5, 13.4, 10.6µg/mL against MCF7, and 21.2, 17.9, 11.7µg/mL against CAL27, respectively. Compounds 1-6 also showed cytotoxicity against HEK293 with IC50 values ranging from 10 to 150µg/mL, respectively.
CONCLUSIONS: The traditional extraction protocol using boiled water afforded three moderately active lignans 1-3. Ethanol extraction, which is widely used in the preparation of herbal remedies in China, yielded three additional active compounds 4-5 with more potent activities. These results provided a rationale for the traditional application of the ethnic Yao medicine Baizuan in the treatment of cancer.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Baizuan; Dibenzocyclooctadiene lignans; Schisandra viridis; Triterpenoids

Mesh:

Substances:

Year:  2016        PMID: 27620660     DOI: 10.1016/j.jep.2016.09.016

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Gnetum montanum extract induces apoptosis by inhibiting the activation of AKT in SW480 human colon cancer cells.

Authors:  Xianglong Pan; Xiaotao Hou; Fan Zhang; Peiling Tang; Wanruo Wan; Zixia Su; Yeguo Yang; Wei Wei; Zhengcai Du; Jiagang Deng; Erwei Hao
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Gomisin M2 Inhibits Mast Cell-Mediated Allergic Inflammation via Attenuation of FcεRI-Mediated Lyn and Fyn Activation and Intracellular Calcium Levels.

Authors:  Hima Dhakal; Soyoung Lee; Eun-Nam Kim; Jin Kyeong Choi; Min-Jong Kim; Jinjoo Kang; Young-Ae Choi; Moon-Chang Baek; Byungheon Lee; Hyun-Shik Lee; Tae-Yong Shin; Gil-Saeng Jeong; Sang-Hyun Kim
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

3.  Gomisin M2 from Baizuan suppresses breast cancer stem cell proliferation in a zebrafish xenograft model.

Authors:  Yeguo Yang; Erwei Hao; Xianglong Pan; Dechao Tan; Zhengcai Du; Jinling Xie; Xiaotao Hou; Jiagang Deng; Kun Wei
Journal:  Aging (Albany NY)       Date:  2019-10-14       Impact factor: 5.682

4.  Gomisin M2 alleviates psoriasis‑like skin inflammation by inhibiting inflammatory signaling pathways.

Authors:  Namkyung Kim; Soyoung Lee; Jinjoo Kang; Taeg Kyu Kwon; Dongwoo Khang; Sang-Hyun Kim
Journal:  Mol Med Rep       Date:  2021-10-19       Impact factor: 3.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.